Ligand’s Second Quarter Financial Results to be Reported August 3rd

Go back to Ligand’s Second Quarter Financial Results to be Reported August 3rd
LIGAND PHARMA (NASDAQ: LGND) Delayed: 291.77 -2.83 (0.96%)
Previous Close $294.60    52 Week High $139.79 
Open $292.47    52 Week Low $82.07 
Day High $298.29    P/E 678.53 
Day Low $291.73    EPS $0.43 
Volume 145,603